ASPRE Trial: Incidence of Preterm Preeclampsia in Patients Fulfilling ACOG and NICE Criteria According to Risk by FMF Algorithm

(Abstracted from Ultrasound Obstet Gynecol 2018;51:738–742) The current approach to screening for preeclampsia (PE) is to identify risk factors from maternal demographic characteristics and medical history (maternal factors). According to the National Institute for Health and Care Excellence (NICE), in the United Kingdom, women are considered to be at high risk of developing PE if they have any one high-risk factor (hypertensive disease in previous pregnancy, chronic hypertension, chronic renal disease, diabetes mellitus, or autoimmune disease) or any 2 moderate-risk factors (nulliparity, age ≥40 years, body mass index [BMI] ≥35 kg/m2, family history of PE, or interpregnancy interval >10 years).